Real world data (RWD) now plays a pivotal role in informing decisions about access, reimbursement, and comparative effectiveness. Medical and prescription claims data represent traditional sources of secondary data used to conduct real world research, yet those sources sometimes lack key outcomes of interest, especially those focused on disease morbidity or severity.

In this webinar, we'll discuss two commonly used sources of clinical data in depth, which when linked with claims data, help to measure clinically rich outcomes. We will also review analytic approaches to define morbidity and mortality using claims data. Case examples will be reviewed in the clinical areas of oncology, as well as multiple sclerosis.

Speakers

Chi-Chang Chen, MPharm PhD
Principal, Health Economics and Outcomes Research, Real World Evidence, IQVIA